Objective risk assessment guides surveillance and treatment
Patients with Barrett’s esophagus (BE) face a low but consequential risk of progression to esophageal adenocarcinoma, for which treatments are limited. Gastroenterologists need reliable methods to assess progression risk in BE patients ….